Trust Point’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Trust Point's UTHR Position: Q3 2026 in Review
Trust Point increased its United Therapeutics (UTHR) stake by 6% in Q3 2026, buying an estimated $20.7K and bringing the position to 702 shares worth $380K. The position accounts for 0.03% of the portfolio, ranked #319.
Trust Point first reported a position in UTHR in Q2 2024 and has held it in 10 quarters since. The position peaked at $599K in Q4 2024. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Trust Point held 702 shares of United Therapeutics worth $380K as of Q3 2026.
- Trust Point bought 40 United Therapeutics shares in Q3 2026, an estimated $20.7K.
- United Therapeutics made up 0.03% of Trust Point's portfolio in Q3 2026, its #319 holding.
- Trust Point first reported a position in United Therapeutics in Q2 2024 and has held it in 10 quarters since.
- Trust Point's United Therapeutics position peaked at $599K in Q4 2024.
- 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.